Over half (60%) of individuals with heart disease and up to half of those who have had a stroke may not be receiving any of the 4 types of drug – antiplatelet agents, β-blockers, RAAS inhibitors, and statins – that are effective treatments for these conditions, according to PURE (Prospective Urban Rural Epidemiology), an